Drugs / P-3058
P-3058
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03094468 | May 2017 → Oct 2019 | fungal infection of the toenail | Polichem S.A. | Withdrawn | No outcome recorded |
| Phase 3 | NCT02549001 | Aug 2015 → Sep 2018 | tinea unguium | Polichem S.A. | Completed | No outcome recorded |
| Phase 3 | NCT02547701 | Aug 2014 → Sep 2017 | tinea unguium | Polichem S.A. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | P-3058 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02547701 ↗ |
| Known as | terbinafine | “The aim of this phase III study is to establish the efficacy and safety of P-3058 (terbinafine 10% nail solution) topically administered once weekly in patients with...” NCT03094468 ↗ |
| Known as | terbinafine hydrochloride | “P-3058 (terbinafine hydrochloride 10%)” NCT03094468 ↗ |
| Route | Topical | “treated topically with P-3058 nail solution” NCT02547701 ↗ |